Free Trial
CVE:EQ

EQ (EQ) Stock Price, News & Analysis

EQ logo
C$0.97 0.00 (0.00%)
As of 08/1/2025 03:32 PM Eastern

About EQ Stock (CVE:EQ)

Key Stats

Today's Range
C$0.92
C$0.97
50-Day Range
C$0.92
C$1.01
52-Week Range
C$0.90
C$1.15
Volume
9,003 shs
Average Volume
9,561 shs
Market Capitalization
C$67.51 million
P/E Ratio
N/A
Dividend Yield
0.61%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EQ and its competitors with MarketBeat's FREE daily newsletter.

EQ Stock News Headlines

Subaru Forester 2025 vs Mercedes Benz G 580 EQ
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Headlines

EQ Stock Analysis - Frequently Asked Questions

EQ's stock was trading at C$1.06 on January 1st, 2025. Since then, EQ stock has decreased by 8.5% and is now trading at C$0.97.

Shares of EQ stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that EQ investors own include Revvity (PKI), Norwegian Cruise Line (NCLH), Atara Biotherapeutics (ATRA), Denali Therapeutics (DNLI), Esperion Therapeutics (ESPR), Energy Transfer (ET) and Facedrive (FDVRF).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Advertising Agencies
Sub-Industry
Pharmaceutical Products
Current Symbol
CVE:EQ
CIK
N/A
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$4.66 million
Net Margins
-48.08%
Pretax Margin
N/A
Return on Equity
356.88%
Return on Assets
-18.43%

Debt

Debt-to-Equity Ratio
-105.48
Current Ratio
0.77
Quick Ratio
1.27

Sales & Book Value

Annual Sales
C$9.70 million
Price / Sales
6.96
Cash Flow
C$0.04 per share
Price / Cash Flow
23.33
Book Value
C($0.02) per share
Price / Book
-54.32

Miscellaneous

Outstanding Shares
69,594,000
Free Float
N/A
Market Cap
C$67.51 million
Optionable
Not Optionable
Beta
-0.05
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (CVE:EQ) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners